Category: Include on Menu

  • C3 AI Shares Gain After Company Wins U.S. Army Contract for Battlefield Logistics Technology

    C3 AI Shares Gain After Company Wins U.S. Army Contract for Battlefield Logistics Technology

    C3 AI (NYSE:AI) traded 2% higher on Tuesday after announcing it has been awarded a contract by the U.S. Army to build an artificial intelligence–powered logistics system intended to support combat operations. The selection, made by the Army’s Rapid Capabilities and Critical Technologies Office (RCCTO), tasks C3 AI with creating AI-enabled tools that can help…

  • Akari Therapeutics Shares Climb After Encouraging Early Data for Pancreatic Cancer Candidate

    Akari Therapeutics Shares Climb After Encouraging Early Data for Pancreatic Cancer Candidate

    Akari Therapeutics PLC (NASDAQ:AKTX) saw its stock rise 7.9% in premarket trading on Tuesday after unveiling new preclinical findings showing that its investigational antibody-drug conjugate, AKTX-101, successfully eliminated cancer cells carrying K-Ras G12V mutations in pancreatic cancer models. According to the company, AKTX-101—designed to target the Trop2 protein frequently overexpressed in pancreatic tumors—demonstrated “single digit…

  • STAAR Surgical Shares Jump After Alcon Sweetens Its Takeover Bid

    STAAR Surgical Shares Jump After Alcon Sweetens Its Takeover Bid

    STAAR Surgical Company (NASDAQ:STAA) surged 15% in Tuesday’s premarket session after Alcon (NYSE:ALC) announced it has raised its acquisition offer through an amended merger agreement. Under the revised terms, Alcon will acquire all outstanding STAAR shares for $30.75 per share in cash, adding roughly $150 million in equity value for shareholders. The new offer values…

  • Citius Oncology Shares Sink After Announcing $18M Fundraising Deal

    Citius Oncology Shares Sink After Announcing $18M Fundraising Deal

    Citius Oncology Inc. (NASDAQ:CTOR) dropped 13.8% in premarket trading Tuesday after the company unveiled plans to raise roughly $18 million through a combination of registered direct and private placement offerings. The cancer-focused biotech said it reached an agreement with a single institutional healthcare investor to sell shares and warrants at a price of $1.09 per…

  • SLM Shares Slide as Investor Day Signals Slower EPS Growth and Rising Costs

    SLM Shares Slide as Investor Day Signals Slower EPS Growth and Rising Costs

    SLM Corp. (NASDAQ:SLM) saw its stock plunge 14% in premarket trading Tuesday after the company’s 2025 investor day unveiled a much weaker earnings trajectory and higher-than-expected operating costs. The event, held after Monday’s market close, triggered a wave of analyst downgrades. Morgan Stanley cut its rating from Overweight to Equalweight and reduced its price target…

  • Critical Metals Shares Climb After Signing Romanian Rare Earth Processing Partnership

    Critical Metals Shares Climb After Signing Romanian Rare Earth Processing Partnership

    Critical Metals Corp. (NASDAQ:CRML) traded 5% higher in premarket action Tuesday after revealing it has signed a term sheet to establish a 50-50 joint venture with Romania’s state-owned Fabrica de Prelucrare a Concentratelor de Uraniu S.R.L. (FPCU). The pact grants the U.S.-listed miner long-term rights to purchase half of the concentrate produced from its Tanbreez…

  • Academy Sports and Outdoors Shares Rise After Earnings Beat Fueled by Strong Online Sales

    Academy Sports and Outdoors Shares Rise After Earnings Beat Fueled by Strong Online Sales

    Academy Sports and Outdoors (NASDAQ:ASO) saw its stock climb more than 2% in premarket trading Tuesday after the retailer posted quarterly earnings that surpassed expectations, driven by robust eCommerce performance and contributions from new store openings—even as comparable sales edged lower. For the third quarter, the company reported earnings of $1.14 per share, topping analyst…

  • Moleculin Shares Rise 6% as Enrollment Nears Key Milestone in AML Trial

    Moleculin Shares Rise 6% as Enrollment Nears Key Milestone in AML Trial

    Moleculin Biotech Inc. (NASDAQ:MBRX) moved higher in premarket trading on Tuesday, gaining 6.2% after the company announced that enrollment has reached 78% for the first planned interim unblinding in its pivotal Phase 2B/3 MIRACLE study. The clinical-stage drug developer said that 78% of the targeted 45 participants have now consented to join the trial, which…

  • Accenture Shares Gain 1.6% After Deepening AI Partnership with Anthropic

    Accenture Shares Gain 1.6% After Deepening AI Partnership with Anthropic

    Accenture (NYSE:ACN) traded higher on Tuesday, rising 1.6% after the company revealed an expanded collaboration with Anthropic aimed at accelerating enterprise adoption of artificial intelligence technologies. As part of the enhanced alliance, the two firms are launching the Accenture Anthropic Business Group — an initiative that will train roughly 30,000 Accenture employees to use Anthropic’s…

  • Top Wealth Group Shares Plunge 70% After Announcing $5.04 Million Public Offering

    Top Wealth Group Shares Plunge 70% After Announcing $5.04 Million Public Offering

    Top Wealth Group Holding Limited (NASDAQ:TWG) saw its shares collapse by 70% early Tuesday, erasing a massive 266% surge from the previous session, after the company unveiled the pricing of a new public offering worth $5.04 million. The premium sturgeon caviar and winery products supplier priced a best-efforts offering of 720,000 units at $7.00 each.…